Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01099397 · ClinicalTrials.gov registry record
Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 26
- Enrollment target
NCT01099397 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 26 participants.
The verdict
NCT01099397 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if, in a subset of patients treated with a beta-blocker and diuretic, prediabetes is detectable to a greater extent through a 2-hour oral glucose tolerance test (OGTT) compared to fasting glucose measurement.
Interventions
- OTHER Oral glucose tolerance test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01099397
The ClinicalTrials.gov registry entry for NCT01099397 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral glucose tolerance test is the first listed.
NCT01099397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01099397 about?
NCT01099397 is a clinical study titled "Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study". The purpose of this study is to determine if, in a subset of patients treated with a beta-blocker and diuretic, prediabetes is detectable to a greater extent through a 2-hour oral glucose tolerance test (OGTT) compared to fasting glucose measurement.
What is the current status of trial NCT01099397?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2009-05. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01099397?
The interventions under investigation include: Oral glucose tolerance test (OTHER).
Who is sponsoring clinical trial NCT01099397?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.